Quinidine-induced recurrent ventricular fibrillation: (quinidine syncope) treated with transvenous pacemaker.
D000328:Adult; D001281:Atrial Fibrillation / Q000188:drug therapy; D001285:Atropine / Q000627:therapeutic use; D001772:Blood Cell Count; D002746:Chlorpromazine / Q000627:therapeutic use; D003374:Coumarins / Q000627:therapeutic use; D003402:Creatine Kinase / Q000097:blood; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004554:Electric Countershock; D004562:Electrocardiography; D005260:Female; D006350:Heart Valve Prosthesis; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D007773:Lactates / Q000627:therapeutic use; D008012:Lidocaine / Q000627:therapeutic use; D008946:Mitral Valve Stenosis / Q000150:complications / Q000601:surgery; D010138:Pacemaker, Artificial; D010259:Paranoid Disorders / Q000188:drug therapy; D011014:Pneumonia / Q000150:complications; D011189:Potassium Chloride / Q000627:therapeutic use; D011802:Quinidine / Q000009:adverse effects* / Q000097:blood; D012214:Rheumatic Heart Disease / Q000150:complications; D013575:Syncope / Q000139:chemically induced; D014693:Ventricular Fibrillation / Q000139:chemically induced* / Q000628:therapy*
D003374:Coumarins; D004071:Digitalis Glycosides; D004232:Diuretics; D007773:Lactates; D011189:Potassium Chloride; D001285:Atropine; D008012:Lidocaine; D007770:L-Lactate Dehydrogenase; D003402:Creatine Kinase; D011802:Quinidine; D002746:Chlorpromazine